Recent Progress in the Development of Anticancer Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
419-439
Author(s):
Sandor Eckhardt
Neopterin as a Marker for Immune System Activation
Journal:
Current Drug Metabolism
Volume:
3
Page:
175-187
Author(s):
C. Murr, B. Widner, B. Wirleitner and D. Fuchs
Physiology of Folic Acid in Health and Disease
Journal:
Current Drug Metabolism
Volume:
3
Page:
211-223
Author(s):
O. Stanger
Vinorelbine in the Treatment of Non-Small Cell Lung Cancer
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
879-891
Author(s):
Cesare Gridelli and Rocco De. Vivo
Metabolism of the Novel IMP Dehydrogenase Inhibitor Benzamide Riboside
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
781-786
Author(s):
Walter Jager, Alexandra Salamon and Thomas Szekeres
Prospects for Anti-Neoplastic Therapies Based on Telomere Biology
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
1-17
Author(s):
sheila A. Stewart and William C. Hahn
Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
55-75
Author(s):
Angela casini, Andrea Scozzafava, Antonio Mastrolorenzo and Claudiu T. Supuran
The Impact of Thrombopoietin on Clinical Practice
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
369-377
Author(s):
Russell Basser
subject Index To Volume 2
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
61-62
Author(s):
Cancer Immunotherapy Using Gene-Modified Dendritic Cells
Journal:
Current Gene Therapy
Volume:
2
Page:
57-78
Author(s):
Antoni Ribas, Lisa H. Butterfield, John A. Glaspy and James S. Economou